CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Acadia Healthcare Company, Inc. - ACHC CFD

86.30
1.22%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.49
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Acadia Healthcare Company Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 85.42
Open* 85.61
1-Year Change* 6.79%
Day's Range* 84.35 - 86.46
52 wk Range 66.49-86.00
Average Volume (10 days) 591.57K
Average Volume (3 months) 10.91M
Market Cap 7.84B
P/E Ratio -100.00K
Shares Outstanding 92.22M
Revenue 2.86B
EPS -0.21
Dividend (Yield %) N/A
Beta 1.32
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 26, 2024 85.42 2.10 2.52% 83.32 86.30 83.17
Feb 23, 2024 83.92 -0.07 -0.08% 83.99 85.05 83.62
Feb 22, 2024 84.17 2.15 2.62% 82.02 84.80 82.02
Feb 21, 2024 83.64 1.67 2.04% 81.97 84.49 80.86
Feb 20, 2024 83.86 2.06 2.52% 81.80 83.86 81.80
Feb 16, 2024 82.80 1.17 1.43% 81.63 83.79 81.63
Feb 15, 2024 83.05 2.07 2.56% 80.98 83.46 80.98
Feb 14, 2024 82.33 1.01 1.24% 81.32 82.78 81.32
Feb 13, 2024 81.90 -0.11 -0.13% 82.01 82.95 78.78
Feb 12, 2024 83.72 2.49 3.07% 81.23 84.36 81.22
Feb 9, 2024 81.96 2.82 3.56% 79.14 82.26 79.14
Feb 8, 2024 80.14 2.08 2.66% 78.06 80.88 77.64
Feb 7, 2024 79.53 -0.13 -0.16% 79.66 80.85 78.96
Feb 6, 2024 79.78 1.05 1.33% 78.73 79.79 78.54
Feb 5, 2024 78.71 -0.46 -0.58% 79.17 79.94 78.22
Feb 2, 2024 80.17 -0.58 -0.72% 80.75 81.44 78.65
Feb 1, 2024 81.70 0.58 0.71% 81.12 82.32 80.81
Jan 31, 2024 81.75 -2.29 -2.72% 84.04 84.53 79.02
Jan 30, 2024 83.84 0.03 0.04% 83.81 85.84 83.81
Jan 29, 2024 84.84 1.56 1.87% 83.28 85.07 82.89

Acadia Healthcare Company, Inc. Events

Time (UTC) Country Event
Tuesday, February 27, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Acadia Healthcare Company Inc Earnings Release
Q4 2023 Acadia Healthcare Company Inc Earnings Release

Forecast

-

Previous

-
Wednesday, February 28, 2024

Time (UTC)

13:00

Country

US

Event

Q4 2023 Acadia Healthcare Company Inc Earnings Call
Q4 2023 Acadia Healthcare Company Inc Earnings Call

Forecast

-

Previous

-
Wednesday, April 24, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Acadia Healthcare Company Inc Earnings Release
Q1 2024 Acadia Healthcare Company Inc Earnings Release

Forecast

-

Previous

-
Friday, May 17, 2024

Time (UTC)

13:00

Country

US

Event

Acadia Healthcare Company Inc Annual Shareholders Meeting
Acadia Healthcare Company Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2610.4 2314.39 2089.93 2008.38 1904.69
Revenue 2610.4 2314.39 2089.93 2008.38 1904.69
Total Operating Expense 2166.5 1961.64 1780.85 1742.66 1652.77
Selling/General/Admin. Expenses, Total 1697.11 1509.76 1399.61 1346.83 1275.14
Depreciation / Amortization 117.769 106.717 95.256 87.923 80.342
Unusual Expense (Income) 2.341 43.821 23.704 48.374 53.61
Other Operating Expenses, Total 349.277 301.339 262.272 259.536 243.671
Operating Income 443.903 352.753 309.083 265.72 251.929
Interest Income (Expense), Net Non-Operating -69.76 -76.993 -158.105 -187.325 -184.534
Net Income Before Taxes 374.143 275.76 183.797 78.395 67.395
Net Income After Taxes 280.033 208.203 143.191 53.31 57.488
Minority Interest -6.894 -4.927 -2.933 -1.199 -0.264
Net Income Before Extra. Items 273.139 203.276 140.258 52.111 57.224
Total Extraordinary Items 0 -12.641 -812.39 56.812 -232.974
Net Income 273.139 190.635 -672.132 108.923 -175.75
Income Available to Common Excl. Extra. Items 273.139 203.276 140.258 52.111 57.224
Income Available to Common Incl. Extra. Items 273.139 190.635 -672.132 108.923 -175.75
Dilution Adjustment
Diluted Net Income 273.139 190.635 -672.132 108.923 -175.75
Diluted Weighted Average Shares 91.555 90.793 87.875 87.816 87.288
Diluted EPS Excluding Extraordinary Items 2.98333 2.2389 1.59611 0.59341 0.65558
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS 3.00247 2.6033 1.80626 0.968 1.17947
Other, Net 32.819
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 731.337 704.267 675.295 666.732 651.719
Revenue 731.337 704.267 675.295 666.732 651.719
Total Operating Expense 613.997 598.625 567.818 551.627 525.497
Selling/General/Admin. Expenses, Total 468.305 469.747 443.588 429.858 416.042
Depreciation / Amortization 32.012 31.569 30.142 29.573 29.128
Unusual Expense (Income) 17.768 6.471 0.166 3.203 -4.61
Other Operating Expenses, Total 95.912 90.838 93.922 88.993 84.937
Operating Income 117.34 105.642 107.477 115.105 126.222
Interest Income (Expense), Net Non-Operating -20.91 -19.999 -19.405 -18.003 -16.565
Net Income Before Taxes 96.43 85.643 88.072 97.102 109.657
Net Income After Taxes 73.549 66.558 63.145 73.046 81.932
Minority Interest -1.25 -0.543 -2.021 -1.947 -1.853
Net Income Before Extra. Items 72.299 66.015 61.124 71.099 80.079
Total Extraordinary Items 0 0 0
Net Income 72.299 66.015 61.124 71.099 80.079
Income Available to Common Excl. Extra. Items 72.299 66.015 61.124 71.099 80.079
Income Available to Common Incl. Extra. Items 72.299 66.015 61.124 71.099 80.079
Diluted Net Income 72.299 66.015 61.124 71.099 80.079
Diluted Weighted Average Shares 91.546 91.391 91.216 91.723 91.473
Diluted EPS Excluding Extraordinary Items 0.78976 0.72234 0.6701 0.77515 0.87544
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.93779 0.77736 0.67141 0.80142 0.83778
Other, Net
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 506.125 495.031 2523.4 542.211 450.417
Cash and Short Term Investments 97.649 133.813 378.697 124.192 50.51
Cash & Equivalents 97.649 133.813 378.697 124.192 50.51
Total Receivables, Net 353.735 304.448 297.083 378.204 352.061
Accounts Receivable - Trade, Net 322.439 281.332 273.551 339.775 318.087
Total Inventory 5.087 4.786 4.851 4.759 5.055
Prepaid Expenses 27.052 22.292 19.48 23.708 30.802
Other Current Assets, Total 22.602 29.692 1823.28 11.348 11.989
Total Assets 4987.9 4768.08 6499.36 6879.14 6172.5
Property/Plant/Equipment, Total - Net 2087.28 1904.92 1719.83 3725.87 3107.77
Property/Plant/Equipment, Total - Gross 2743.86 2446.05 2169.48 4467.65 3593.75
Accumulated Depreciation, Total -656.574 -541.126 -449.643 -741.775 -485.985
Goodwill, Net 2222.8 2199.94 2105.26 2449.13 2396.41
Intangibles, Net 76.041 70.145 68.535 90.357 88.99
Other Long Term Assets, Total 95.647 98.045 82.335 71.572 128.919
Total Current Liabilities 388.326 404.861 1308.19 463.576 416.377
Accounts Payable 104.723 98.575 87.815 127.045 117.74
Accrued Expenses 218.531 219.663 222.607 242.827 224.374
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 22.24 19.584 185.666 50.498 34.112
Other Current Liabilities, Total 42.832 67.039 812.097 43.206 40.151
Total Liabilities 2175.17 2250.59 4599.91 4373.76 3839.2
Total Long Term Debt 1375.4 1489.43 2979.69 3149.08 3159.38
Long Term Debt 1364.54 1478.63 2968.95 3105.42 3159.38
Deferred Income Tax 92.588 74.368 50.017 71.86 80.372
Minority Interest 88.257 65.388 55.315 33.151 28.806
Other Liabilities, Total 230.604 216.539 206.697 656.092 154.267
Total Equity 2812.73 2517.49 1899.46 2505.38 2333.31
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.899 0.89 0.88 0.877 0.874
Additional Paid-In Capital 2658.44 2636.35 2580.33 2557.64 2541.99
Retained Earnings (Accumulated Deficit) 153.388 -119.751 -310.386 361.746 252.823
Other Equity, Total -371.365 -414.884 -462.377
Total Liabilities & Shareholders’ Equity 4987.9 4768.08 6499.36 6879.14 6172.5
Total Common Shares Outstanding 89.9137 89.0282 88.0244 87.7156 87.4445
Capital Lease Obligations 10.858 10.807 10.744 43.662
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 703.475 578.757 537.79 506.125 521.656
Cash and Short Term Investments 99.591 112.173 63.829 97.649 93.419
Cash & Equivalents 99.591 112.173 63.829 97.649 93.419
Total Receivables, Net 515.898 408.889 420.428 353.735 360.509
Accounts Receivable - Trade, Net 362.666 345.836 346.407 322.439 315.999
Total Inventory 5.475 5.437 5.283 5.087 4.854
Prepaid Expenses 38.082 26.883 25.805 27.052 32.554
Other Current Assets, Total 44.429 25.375 22.445 22.602 30.32
Total Assets 5346.22 5150.21 5044.26 4987.9 4943.1
Property/Plant/Equipment, Total - Net 2267.69 2201.66 2131.31 2087.28 2044.62
Property/Plant/Equipment, Total - Gross 3000.88 2916.19 2818.8 2743.86 2671.22
Accumulated Depreciation, Total -733.19 -714.529 -687.489 -656.574 -626.597
Goodwill, Net 2225.96 2222.8 2222.8 2222.8 2207.91
Intangibles, Net 73.811 71.607 76.247 76.041 75.92
Other Long Term Assets, Total 75.281 75.382 76.099 95.647 92.997
Total Current Liabilities 864.89 432.482 378.129 388.326 401.013
Accounts Payable 149.874 148.896 125.729 104.723 116.045
Accrued Expenses 620.431 208.184 185.097 218.531 214.156
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 27.553 24.896 22.24 22.24 22.24
Other Current Liabilities, Total 67.032 50.506 45.063 42.832 48.572
Total Liabilities 2633.66 2229.19 2204.65 2175.17 2199.4
Total Long Term Debt 1349.95 1372.36 1399.78 1375.4 1379.31
Long Term Debt 1349.95 1372.36 1399.78 1364.54 1379.31
Deferred Income Tax 70.45 92.87 92.767 92.588 94.446
Minority Interest 97.582 90.583 90.455 88.257 88.236
Other Liabilities, Total 250.78 240.895 243.525 230.604 236.396
Total Equity 2712.56 2921.02 2839.6 2812.73 2743.71
Common Stock 0.912 0.911 0.91 0.899 0.899
Additional Paid-In Capital 2637.66 2628.4 2619.29 2658.44 2650.54
Retained Earnings (Accumulated Deficit) 73.992 291.702 219.403 153.388 92.264
Total Liabilities & Shareholders’ Equity 5346.22 5150.21 5044.26 4987.9 4943.1
Total Common Shares Outstanding 91.2045 91.1287 90.9531 89.9137 89.8746
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Other Equity, Total
Capital Lease Obligations 10.858
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 280.033 195.562 -669.199 110.122 -175.486
Cash From Operating Activities 380.569 374.477 583.756 308.247 414.08
Cash From Operating Activities 117.769 106.717 95.256 87.923 158.832
Deferred Taxes 16.545 11.772 53.108 1.089 -9.714
Non-Cash Items 35.576 103.929 941.467 128.433 404.06
Cash Taxes Paid 86.195 79.304 -16.486 31.915 6.72
Cash Interest Paid 65.687 93.669 137.578 173.239 175.204
Changes in Working Capital -69.354 -43.503 163.124 -19.32 36.388
Cash From Investing Activities -305.83 1013.1 -281.839 -201.141 -360.964
Capital Expenditures -296.149 -244.811 -224.964 -232.679 -359.845
Other Investing Cash Flow Items, Total -9.681 1257.91 -56.875 31.538 -1.119
Cash From Financing Activities -110.903 -1636.53 -51.499 -61.627 -67.33
Financing Cash Flow Items 2.691 4.379 -25.607 -8.643 -2.265
Issuance (Retirement) of Stock, Net 0.184 -3.407
Issuance (Retirement) of Debt, Net -113.594 -1640.9 -26.076 -52.984 -61.658
Foreign Exchange Effects 0 4.067 4.087 3.546 -2.566
Net Change in Cash -36.164 -244.884 254.505 49.025 -16.78
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 66.558 280.033 216.888 143.842 61.91
Cash From Operating Activities 44.408 380.569 267.025 225.989 76.787
Cash From Operating Activities 31.569 117.769 87.627 58.054 28.926
Deferred Taxes 0.212 16.545 20.176 7.975 3.269
Non-Cash Items 9.542 35.576 26.607 16.521 8.255
Changes in Working Capital -63.473 -69.354 -84.273 -0.403 -25.573
Cash From Investing Activities -66.91 -305.83 -213.81 -135.786 -49.693
Capital Expenditures -66.525 -296.149 -208.792 -132.444 -50.527
Other Investing Cash Flow Items, Total -0.385 -9.681 -5.018 -3.342 0.834
Cash From Financing Activities -11.318 -110.903 -93.609 -95.648 -20.54
Financing Cash Flow Items -46.005 2.691 4.672 -2.679 -7.884
Issuance (Retirement) of Debt, Net 34.687 -113.594 -98.281 -92.969 -12.656
Foreign Exchange Effects 0 0 0 0
Net Change in Cash -33.82 -36.164 -40.394 -5.445 6.554
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.5322 8785962 -304311 2023-06-30 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 8.8052 8115908 833620 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 8.0227 7394665 -138617 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 8.0124 7385139 1758293 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 5.0458 4650780 291727 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 3.9676 3657029 -314238 2023-06-30 LOW
Viking Global Investors LP Investment Advisor/Hedge Fund 3.5161 3240894 -113216 2023-06-30 MED
William Blair Investment Management, LLC Investment Advisor/Hedge Fund 3.3078 3048854 504572 2023-06-30 LOW
Invesco Advisers, Inc. Investment Advisor 3.0815 2840263 101904 2023-06-30 LOW
JP Morgan Asset Management Investment Advisor 2.8377 2615589 -6009 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.7814 2563638 22019 2023-06-30 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 2.0513 1890711 153854 2023-06-30 LOW
Fred Alger Management, LLC Investment Advisor/Hedge Fund 1.8127 1670779 -285262 2023-06-30 MED
Stephens Investment Management Group, LLC Investment Advisor 1.5928 1468089 30525 2023-06-30 LOW
Hawk Ridge Capital Management LP Hedge Fund 1.5386 1418141 139552 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5381 1417694 71021 2023-06-30 LOW
Durable Capital Partners LP Hedge Fund 1.5066 1388667 -487441 2023-06-30 LOW
P2 Capital Partners, LLC Hedge Fund 1.4864 1370000 0 2023-06-30 LOW
Polar Capital LLP Investment Advisor/Hedge Fund 1.2784 1178312 138008 2023-06-30 LOW
Neuberger Berman, LLC Investment Advisor/Hedge Fund 1.2574 1158944 4354 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Acadia Healthcare Company, Inc. Company profile

About Acadia Healthcare Company Inc

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services in the United States. The Company is focused on acquiring and developing behavioral healthcare facilities. It is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities in which it operates. Its facilities that offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery model that incorporates medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and other direct care staff. Its specialty treatment facilities include residential recovery facilities, eating disorder facilities and comprehensive treatment centers (CTCs).

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Acadia Healthcare Company Inc revenues increased 11% to $2.31B. Net income before extraordinary items increased 45% to $203.3M. Revenues reflect Patient Days - Total increase of 4% to 2.8M. Net income benefited from Interest expense, net - Balancing value decrease of 52% to $74.8M (expense), Interest Expense on Financial Lease Liab decrease of 32% to $2.2M (expense).

Equity composition

Insiders 14.91%

Industry: Healthcare Facilities & Services (NEC)

Suite 610
830 Crescent Centre Drive
FRANKLIN
TENNESSEE 37067
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Gold

2,033.14 Price
+0.080% 1D Chg, %
Long position overnight fee -0.0189%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

56,605.45 Price
+4.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

17,954.80 Price
+0.240% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

78.25 Price
+0.950% 1D Chg, %
Long position overnight fee 0.0054%
Short position overnight fee -0.0273%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading